Jean-Marc Pardonge has become the new president of Aptar Pharma’s prescription division, a firm that works in the development and manufacturing of nasal and pulmonary drug delivery devices.

Pardonge succeeds Salim Haffar, and also becomes the new general manager of Aptar Stelmi (the Stelmi company was recently acquired by Aptargroup).

After graduating from the French ENSAM engineering school (Ecole Nationale Supérieure d’Arts et Métiers), Pardonge joined Aptar Pharma prescription division in 2000 as R&D manager. He was promoted to the position as the VP of research in 2003.

In January 2010, he became president of global market development at Aptar Pharma’s prescription division.

In this role, he managed and co-ordinated worldwide activities which included scientific and regulatory affairs, business development, communication, engineering, innovation, marketing, projects, and R&D.